Advertisement

Chest Surgery pp 217-228 | Cite as

Lymph Node Dissection

  • Alper TokerEmail author
Chapter
Part of the Springer Surgery Atlas Series book series (SPRISURGERY)

Abstract

A major determinant of survival in non-small cell lung cancer (NSCLC) patients is nodal status. Positron emission tomography and CT are the most commonly used imaging methods to assess the status of mediastinal lymph nodes. However, the surgeon plays a critical role in the accurate assessment of nodal involvement during thoracotomy and resection through videothoracoscopic surgery (VATS).

Keywords

Mediastinal Lymph Node Main Bronchus Bronchial Artery Azygos Vein Inferior Pulmonary Vein 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. Allen MS, Darling GE, Pechet TT et al (2006) Morbidity and mortality of major lung resections in patients with early stage lung cancer. Initial results of the randomized, prospective ACOSOG Z0030 trial. Ann Thorac Surg 81:1013–1019PubMedCrossRefGoogle Scholar
  2. Darling GE, Allen MS, Decker P, Ballman KV, Landrenau RJ, McKenna RJ, Jones DR, Inculet RI, Rusch VW, Putnam JB (2010) Randomized trial of mediastinal lymph node sampling versus complete lymphadenectomy during pulmonary resection in patients with N0 or N1 (less than hilar) non small cell carcinoma: results of the ACOSOG Z0030 trial. In: 90th annual meeting of the American Association for Thoracic Surgery, Toronto, 1–5 MayGoogle Scholar
  3. Detterbeck F (2008) What to do with “surprise” N2? Intraoperative management of patients with non-small cell lung cancer. J Thorac Oncol 3(3):289–302PubMedCrossRefGoogle Scholar
  4. Izbicki JR, Thetter O, Habekost M et al (1994) Radical systematic lymphadenectomy in non-small cell lung cancer patients. A randomized controlled trial. Br J Surg 81:229–235PubMedCrossRefGoogle Scholar
  5. Keller SM, Adak S, Wagner H, Johnson DH (2000) Mediastinal lymph node dissection improves survival in patients with stage II and IIIa non-small cell lung cancer. Eastern Cooperative Oncology Group. Ann Thorac Surg 70:358–365PubMedCrossRefGoogle Scholar
  6. Lardinois D, De Leyn P, Van Schil P, Porta RR, Waller D, Passlick B, Zielinski M, Lerut T, Weder W (2006) ESTS guidelines for intraoperative lymph node staging in non-small cell lung cancer. Eur J Cardiothorac Surg 30:787–792PubMedCrossRefGoogle Scholar
  7. Naruke T (1994) Mediastinal lymph node dissection. In: Shields TW (ed) General thoracic surgery, 4th edn. Williams and Wilkins, Baltimore, pp 469–491Google Scholar
  8. Toker A, Tanju S, Ziyade S, Kaya S, Erus S, Yılmazbayhan D (2011) Alternative paratracheal lymph node dissection in left-sided hilar lung cancer patients: comparing the number of lymph nodes dissected to the number of lymph nodes dissected in right-sided mediastinal dissections. Eur J Cardiothorac Surg 39(6):974–980PubMedCrossRefGoogle Scholar
  9. Whitson BA, Groth SS, Maddaus MA (2007) Surgical assessment and intraoperative management of mediastinal lymph nodes in non-small cell lung cancer. Ann Thorac Surg 84:1059–1065PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2015

Authors and Affiliations

  1. 1.Department of Thoracic SurgeryIstanbul Medical School, Istanbul UniversityCapa, IstanbulTurkey

Personalised recommendations